Led · Equity · Mar 2018

Minakem is a contract manufacturing company that provides custom development and manufacturing of building blocks, intermediates and active pharmaceutical ingredients (APIs) for the pharmaceutical industry. The company operates three facilities in Dunkirk and Beuvry la Forêt in France and Louvain-la-Neuve in Belgium. Minakem has expertise in complex multi-step synthesis, pressure chemistry, chiral synthesis, halogenation chemistry, steroid chemistry and 'prazole' chemistry. It employs more than 450 people. The company received a €14.5M investment from its parent company, Minafin. Minakem is using the funds to expand and upgrade manufacturing capacity at its Dunkirk site, increasing total site capacity to 148m3.